Therefore, future studies should focus on uncovering whether CSN6 functions are integral to the circumvention of ARVC deficits and premature lethality associated with PKP2 gene therapy in PKP2 Hom mice. Here, PKP2 is linked to Arrhythmogenic right ventricular dysplasia.